The Journal of Organic Chemistry
Article
Hz, 3F). HRMS (ESI+) m/z: [M + H]+ calcd for C12H12N2OF3S,
289.0617; found, 289.0637.
(s, 3H). 13C{1H} NMR (151 MHz, DMSO-d6) δ = 171.4, 156.3,
153.4, 121.8, 123.7 (q, J = 280.8 Hz), 114.5, 55.1, 42.5 (q, J = 34.9
Hz), 32.2. 19F NMR (565 MHz, CDCl3) δ = −69.68 (t, J = 8.7 Hz,
3F). HRMS (ESI+) m/z: [M + H]+ calcd for C12H12N2O2F3S,
305.0572; found, 305.0560.
(2Z)-2-(2-Methoxyphenyl)imino-3-(2,2,2-trifluoroethyl)-
thiazolidin-4-one (2k). According to the general procedure, 1k (400
mg, 1.8 mmol), DIPEA (1.23 mL, 7.1 mmol), and TFE (0.32 mL, 4.4
mmol) were used affording the pure mixture of regioisomers 2k and
3k (90% yield, 426 mg, ratio 36:64). 1H NMR (400 MHz, CDCl3) δ
= 7.17−7.11 (m, 1H), 6.98−6.91 (m, 2H), 6.90−6.84 (m, 1H), 4.57
(q, J = 8.5 Hz, 2H), 3.88 (s, 2H), 3.81 (s, 3H). 13C{1H} NMR (101
MHz, CDCl3) δ = 171.0, 153.5, 150.6, 136.2, 125.9, 123.3 (q, J =
281.7 Hz), 121.4, 121.0, 112.2, 55.8, 42.9 (q, J = 36.1 Hz), 32.5. 19F
NMR (377 MHz, CDCl3) δ = −69.24 (t, J = 17.0 Hz, 3F). HRMS
(ESI+) m/z: [M + H]+ calcd for C12H12N2O2F3S, 305.0566; found,
305.0583.
(2Z)-2-(4-Chlorophenyl)imino-3-(2,2,2-trifluoroethyl)thiazolidin-
4-one (2e). According to the general procedure, 1e (400 mg, 1.8
mmol), DIPEA (1.23 mL, 7.1 mmol), and TFE (0.32 mL, 4.4 mmol)
were used affording the pure mixture of regioisomers 2e and 3e (78%
1
yield, 426 mg, ratio 91:9). H NMR (600 MHz, CDCl3) δ = 7.34−
7.32 (m, 2H), 6.93−6.89 (m, 2H), 4.53 (q, J = 8.4 Hz, 2H), 3.92 (s,
2H). 13C{1H} NMR (151 MHz, CDCl3) δ = 170.7, 156.9, 151.8,
139.9, 121.8, 123.2 (q, J = 280.7 Hz), 114.4, 55.3, 42.8 (q, J = 36.1
Hz), 32.2. NMR (151 MHz, CDCl3) δ = 170.6, 153.1, 145.5, 130.3,
129.4, 122.2, 123.2 (q, J = 280.7 Hz), 43.0 (q, J = 36.1 Hz), 32.4. 19F
NMR (565 MHz, CDCl3) δ = −67.83 (t, J = 9.1 Hz, 3F). HRMS (ESI
+) m/z: [M + H]+ calcd for C11H9ClN2OF3S, 309.0076; found,
309.0067.
(2Z)-2-(2-Fluorophenyl)imino-3-(2,2,2-trifluoroethyl)thiazolidin-
4-oneone (2f). According to the general procedure, 1f (480 mg, 2.3
mmol), DIPEA (1.67 mL, 9.6 mmol), and TFE (0.43 mL, 5.9 mmol)
were used. Flash column chromatography from 0 to 30% EtOAc in
CyH afforded the pure mixture of regioisomers 2f and 3f (94% yield,
(2Z)-2-(2,4-Di(methoxy)phenyl)imino-3-(2,2,2-trifluoroethyl)-
thiazolidin-4-one (3l). According to the general procedure, 1l (200
mg, 0.8 mmol), DIPEA (0.55 mL, 3.2 mmol), and TFE (0.14 mL, 2.0
mmol) were used. DMAc afforded the pure mixture of regioisomers 2l
and 3l with 74% yield (198 mg, ratio 25:75). Toluene afforded the
pure mixture of regioisomers 2l and 3l with 42% yield (112 mg, ratio
1
626 mg, ratio 85:15). H NMR (600 MHz, CDCl3) δ = 7.16−7.10
(m, 3H), 7.01−6.96 (m, 1H), 4.56 (q, J = 8.3 Hz, 2H), 3.93 (s, 2H).
13C{1H} NMR (151 MHz, CDCl3) δ = 170.6, 154.8, 153.4 (d, J =
1
7:93). H NMR (600 MHz, CDCl3) δ = 7.23 (d, J = 8.7 Hz, 1H),
247.0 Hz), 134.7 (d, J = 12.3 Hz), 126.0 (d, J = 7.5 Hz), 124.5 (d, J =
3.6 Hz), 122.5 (d, J = 1.5 Hz), 123.2 (q, J = 280.7 Hz), 116.4 (d, J =
19.6 Hz), 42.9 (q, J = 36.3 Hz), 32.5. 19F NMR (565 MHz, CDCl3) δ
= −67.87 (t, J = 9.1 Hz, 3F), −125.7 (m, 1F). HRMS (ESI+) m/z:
[M + H]+ calcd for C11H9N2OF4S, 293.0372; found, 293.0364.
(2Z)-3-(2,2,2-Trifluoroethyl)-2-[2-(trifluoromethyl)phenyl]imino-
thiazolidin-4-one (2g). According to the general procedure, 1g (400
mg, 1.8 mmol), DIPEA (1.23 mL, 7.1 mmol), and TFE (0.32 mL, 4.4
mmol) were used affording the pure mixture of regioisomers 2g and
3g (96% yield, 426 mg, ratio 96:4). 1H NMR (400 MHz, CDCl3) δ =
7.71−7.64 (m, 1H), 7.51 (tdd, J = 8.0, 1.5, 0.7 Hz, 1H), 7.26−7.21
(m, 1H), 7.01 (ddd, J = 7.9, 1.3, 0.7 Hz, 1H), 4.53 (q, J = 8.5 Hz,
2H), 3.94 (s, 2H). 19F NMR (377 MHz, CDCl3) δ = −61.96 (3F),
−69.27 (t, J = 8.5 Hz, 3F). 13C{1H} NMR (126 MHz, CDCl3) δ =
170.7, 154.4, 145.3, 132.8, 126.9 (q, J = 5.0 Hz), 124.7, 124.7, 123.2
(q, J = 280.7 Hz), 122.3 (q, J = 30.4 Hz), 121.2, 43.0 (q, J = 36.5 Hz),
32.5. HRMS (ESI+) m/z: [M + H]+ calcd for C12H9N2OF6S,
343.0334; found, 343.0337.
6.56 (d, J = 2.6 Hz, 1H), 6.53 (dd, J = 2.6, 8.7 Hz, 1H), 5.24−5.17
(m, 1H), 4.00−3.94 (m, 1H), 3.91 (q, J = 15.7 Hz, 2H), 3.86 (s, 3H),
3.86 (s, 3H). 13C{1H}NMR (151 MHz, CDCl3) δ = 188.3, 187.5,
162.3, 155.9, 131.2, 123.6 (q, J = 280.3 Hz), 120.6, 104.6, 99.7, 55.8,
55.6, 52.5 (q, J = 34.1 Hz), 41.4. 19F NMR (565 MHz, CDCl3) δ =
−69.45 (t, J = 8.7 Hz, 3F). HRMS (ESI+) m/z: [M + H]+ calcd for
C13H14N2O3F3S, 335.0677; found, 335.0673.
(2Z)-2-(2-Pyridylimino)-3-(2,2,2-trifluoroethyl)thiazolidin-4-one
(2m). According to the general procedure, 1m (500 mg, 2.6 mmol),
DIPEA (1.80 mL, 10.3 mmol), and TFE (0.47 mL, 6.5 mmol) were
used affording pure regioisomer 2m (78% yield, 555 mg, beige solid,
1
mp 110−113 °C). H NMR (600 MHz, DMSO-d6) δ = 8.46−8.38
(m, 1H), 7.88−7.79 (m, 1H), 7.21−7.12 (m, 2H), 4.64 (q, J = 9.1 Hz,
2H), 4.04 (s, 2H). 13C{1H} NMR (151 MHz, DMSO-d6) δ = 171.8,
157.6, 157.2, 146.7, 138.6, 123.7 (q, J = 280.7 Hz), 120.7, 120.3, 42.6
(q, J = 34.9 Hz), 32.6. 19F NMR (565 MHz, DMSO-d6) δ = −67.71
(t, J = 9.1 Hz, 3F). HRMS (ESI+) m/z: [M + H]+ calcd for
C10H9N3OF3S, 276.0418; found, 276.0410.
(2Z)-3-(2,2,2-Trifluoroethyl)-2-[4-(trifluoromethyl)phenyl]imino-
thiazolidin-4-one (2h). According to the general procedure, 1h (400
mg, 1.5 mmol), DIPEA (1.07 mL, 6.1 mmol), and TFE (0.28 mL, 3.8
mmol) were used. Flash column chromatography from 0 to 30%
EtOAc in CyH afforded the pure mixture of regioisomers 2h and 3h
(2Z)-2-Thiazol-2-ylimino-3-(2,2,2-trifluoroethyl)thiazolidin-4-
one (2n). According to the general procedure, 1n (500 mg, 2.5
mmol), DIPEA (1.75 mL, 10.0 mmol), and TFE (0.45 mL, 6.3 mmol)
were used. Flash column chromatography from 0 to 45% EtOAc in
CyH afforded the pure mixture of regioisomers 2n and 3n
(quantitative yield, 745 mg, ratio 59:41, yellow solid, mp 133−139
1
(96% yield, 503 mg, ratio 95:5). H NMR (600 MHz, CDCl3) δ =
7.63 (d, J = 8.3 Hz, 2H), 7.06 (d, J = 8.1 Hz, 2H), 4.55 (q, J = 8.5 Hz,
2H), 3.95 (s, 2H). 13C{1H} NMR (151 MHz, CDCl3) δ = 170.5,
153.6, 150.1, 127.1 (q, J = 32.6 Hz), 126.6 (q, J = 3.6 Hz), 124.1 (q, J
= 271.6 Hz), 123.1 (q, J = 280.7 Hz), 121.1, 43.0 (q, J = 36.3 Hz),
32.5. 19F NMR (565 MHz, CDCl3) δ = −62.09 (s, 3F), −69.18 (t, J =
8.2 Hz, 3F). HRMS (ESI+) m/z: [M + H]+ calcd for C12H9N2OF6S,
343.0340; found, 343.0334.
1
°C). H NMR (600 MHz, DMSO-d6) δ = 7.66 (d, J = 3.7 Hz, 1H),
7.50 (d, J = 3.7 Hz, 1H), 4.58 (q, J = 9.2 Hz, 2H), 4.17 (s, 2H).
13C{1H} NMR (151 MHz, DMSO-d6) δ = 171.8, 168.3, 160.1, 140.0,
123.5 (q, J = 280.5 Hz), 117.7, 42.6 (q, J = 34.9 Hz), 33.2. 19F NMR
(565 MHz, DMSO-d6) δ = −67.75 (t, J = 9.1 Hz, 3F). HRMS (ESI+)
m/z: [M + H]+ calcd for C8H7N3OF3S2, 281.9953; found, 281.9977.
(2Z)-3-(2,2,3,3,3-Pentafluoropropyl)-2-phenylimino-thiazolidin-
4-one (2o). According to the general procedure, 1o (400 mg, 2.1
mmol), DIPEA (1.45 mL, 8.3 mmol), and 2,2,3,3,3-pentafluoropro-
panol (0.52 mL, 5.2 mmol) were used. Flash column chromatography
from 0 to 30% EtOAc in CyH afforded the pure mixture of
(2Z)-2-(4-Nitrophenyl)imino-3-(2,2,2-trifluoroethyl)thiazolidin-4-
one (2i). According to the general procedure, 1i (400 mg, 1.7 mmol),
DIPEA (1.17 mL, 6.7 mmol), and TFE (0.31 mL, 4.2 mmol) were
1
used affording pure regioisomers 2i (86% yield, 465 mg). H NMR
(600 MHz, CDCl3) δ = 8.26−8.22 (m, 2H), 7.10−7.05 (m, 2H), 4.54
(q, J = 8.4 Hz, 2H), 3.98 (s, 2H). 13C{1H} NMR (151 MHz, CDCl3)
δ = 170.3, 154.3, 152.9, 144.8, 125.2, 121.5, 123.0 (q, J = 280.7 Hz),
43.0 (q, J = 36.4 Hz), 32.5. 19F NMR (565 MHz, CDCl3) δ = −67.85
(m, 3F). HRMS (ESI+) m/z: [M + H]+ calcd for C11H9N3O3F3S,
320.0317; found, 320.0306.
1
regioisomers 2o and 3o (55% yield, 370 mg, ratio 81:19). H NMR
(600 MHz, DMSO-d6) δ = 7.39 (t, J = 7.6 Hz, 2H), 7.16 (t, J = 7.4
Hz, 1H), 6.92 (d, J = 7.7 Hz, 2H), 4.59 (t, J = 15.1 Hz, 2H), 4.19 (s,
2H). 13C{1H} NMR (151 MHz, DMSO-d6) δ = 171.5, 154.1, 147.2,
129.4, 124.6, 120.6, 118.4 (q, J = 273.5 Hz), 112.6 (dt, J = 37.5, 256.7
Hz), 40.6 (t, J = 24.1 Hz), 32.3. 19F NMR (565 MHz, DMSO-d6) δ =
−83.83 (s, 3F), −117.95 (t, J = 15.2 Hz, 2F). HRMS (ESI+) m/z: [M
+ H]+ calcd for C12H10N2OF5S, 325.0434; found, 325.0432.
(2Z)-3-Ethyl-2-phenylimino-thiazolidin-4-one (2p). According to
the general procedure, 1p (300 mg, 1.6 mmol), DIPEA (1.09 mL, 6.2
mmol), and ethanol (0.23 mL, 3.9 mmol) were used affording the
(2Z)-2-(4-Methoxyphenyl)imino-3-(2,2,2-trifluoroethyl)-
thiazolidin-4-one (2j). According to the general procedure, 1j (500
mg, 2.2 mmol), DIPEA (1.57 mL, 5.6 mmol), and TFE (0.41 mL, 5.6
mmol) were used affording the pure mixture of regioisomers 2j and 3j
1
(77% yield, 524 mg, ratio 76:24). H NMR (600 MHz, CDCl3) δ =
6.94 (q, J = 8.3 Hz, 4H), 4.56 (q, J = 8.3 Hz, 2H), 3.92 (s, 2H), 3.83
G
J. Org. Chem. XXXX, XXX, XXX−XXX